Your shopping cart is empty.

COLONgenes

DNA test to preventively know the risk of colorectal carcinoma
DNA test to preventively know the risk of colorectal carcinoma
Colorectal cancer includes any type of tumors of the colon, rectum and appendix. It is thought that most cases of colorectal cancer arise from adenomatous polyps in the colon. COLONgenes evaluates risk of colon cancer.
449,00

Sample type:

Saliva

Delivery period:

30 - 40 days from sample receipt.
Last update of the document Jun, 10/06/2019 - 11:02

Colorectal carcinoma risk DNA test

Colorectal carcinoma (CRC) is a common form of cancer with a high mortality if it is not detected in an early and benign stage, which is characterized by the presence of polyps (the origin of CRC in 90% of the cases).

The degeneration of a benign polyp progresses very slowly over 10 or 15 years. The disease primarily affects older people and can be explained by an accumulation of genetic mutations in the cells of the intestinal mucosa. Besides these accumulated mutations, there have been identified several inheritable genetic variants that increase the relative risk of developing CRC.

In addition, several heritable genetic variants have been identified, which increase the relative risk of developing a colorectal carcinoma. It is a disease that has both a genetic and environmental component.

COLONgenes profile to assess the relative genetic risk of sporadic CRC. The risk of developing colorectal cancer can be reduced by strictly following the guidelines in the profile.

Sporadic colorectal carcinoma is a multifactorial disease that in 90% of cases has a genetic and environmental component.

Proinflammatory diets are a major cause of sporadic colon cancer.

COLONgenes should be prescribed for people with a family history of colon cancer or who have intestinal polyps.

COLONgenes informs about the individual risk factor to suffer a colon cancer, in relation to the general population and offers nutritional recommendations, dietary supplements and lifestyle more suitable for each person, in order to avoid the development of the disease.

This text has been translated automatically using an electronic translator, so the Spanish version should prevail. Please check in case of doubt.

You will receive the sample collection kit. You can request additional kits if you need it.

Sample collection kit content:
You will get a box with sample collection kit. Within the kit you will find:

  1. Saliva collector.
  2. Instructions for the sample collection.
  3. Informed consent sheet and application form.
  4. Security bag to enter the sample for shipment.
  5. Envelope bag.

Process to follow:

  1. Follow the instructions for collecting the sample.
  2. After obtaining the sample, include it in the return envelope, remember to put into the informed consent sheet and the application form.
  3. No shipping costs on Spanish territory.
  4. An email confirmation will be sent when your sample si received.
  5. When the study will be completed you will receive a new e-mail to inform you that your report is already available in "My results".

Info producto mobile

Profile Information

Colorectal carcinoma risk DNA test

Colorectal carcinoma (CRC) is a common form of cancer with a high mortality if it is not detected in an early and benign stage, which is characterized by the presence of polyps (the origin of CRC in 90% of the cases).

The degeneration of a benign polyp progresses very slowly over 10 or 15 years. The disease primarily affects older people and can be explained by an accumulation of genetic mutations in the cells of the intestinal mucosa. Besides these accumulated mutations, there have been identified several inheritable genetic variants that increase the relative risk of developing CRC.

In addition, several heritable genetic variants have been identified, which increase the relative risk of developing a colorectal carcinoma. It is a disease that has both a genetic and environmental component.

COLONgenes profile to assess the relative genetic risk of sporadic CRC. The risk of developing colorectal cancer can be reduced by strictly following the guidelines in the profile.

Sporadic colorectal carcinoma is a multifactorial disease that in 90% of cases has a genetic and environmental component.

Proinflammatory diets are a major cause of sporadic colon cancer.

COLONgenes should be prescribed for people with a family history of colon cancer or who have intestinal polyps.

COLONgenes informs about the individual risk factor to suffer a colon cancer, in relation to the general population and offers nutritional recommendations, dietary supplements and lifestyle more suitable for each person, in order to avoid the development of the disease.

This text has been translated automatically using an electronic translator, so the Spanish version should prevail. Please check in case of doubt.

Sample type and process to follow

You will receive the sample collection kit. You can request additional kits if you need it.

Sample collection kit content:
You will get a box with sample collection kit. Within the kit you will find:

  1. Saliva collector.
  2. Instructions for the sample collection.
  3. Informed consent sheet and application form.
  4. Security bag to enter the sample for shipment.
  5. Envelope bag.

Process to follow:

  1. Follow the instructions for collecting the sample.
  2. After obtaining the sample, include it in the return envelope, remember to put into the informed consent sheet and the application form.
  3. No shipping costs on Spanish territory.
  4. An email confirmation will be sent when your sample si received.
  5. When the study will be completed you will receive a new e-mail to inform you that your report is already available in "My results".

Documentación